BSECompany Update2d ago · 27 Jul 2026, 12:03 pm

Intimation for Earnings call to be held on Wednesday, 5th August 2026

Sudeep Pharma Ltd · 544619

✦ AI SummaryResults

Sudeep Pharma Ltd schedules earnings call with analysts/investors on August 5, 2026, to discuss Q1FY27 financial results.

Analysis Scores

Earnings Impact8/10
Growth Catalyst5/10
Governance Concern1/10
Regulatory Risk2/10
Balance Sheet Risk3/10
Liquidity Impact9/10
Market Sentiment6/10

✦ Ask a Question

Ask anything about this announcement — AI will answer based on the filing content.

0/500

Full Announcement

Sudeep Pharma Ltd - 544619 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

Attachments (1)

📄

dc7e89c3-990e-443e-8b51-755e9f1877ff.pdf

pdf

Download →
View document text
Date: 27th July 2026 National Stock Exchange of India Limited BSE Limited Phiroze Jeejeebhoy Towers Exchange Plaza, C-1, Block G Bandra Kurla Dalal Street, Mumbai – 400001 Complex, Bandra (E), Mumbai – 400051 Scrip Code: 544619 Scrip Symbol- SUDEEPPHRM Sub: Intimation of Earnings Call with Analysts/Investors on 5th August 2026 Ref: Regulation 30 of the SEBI Listing Regulations, 2015 Dear Sir/Ma’am, This is to inform that the “Earnings Call” of the Company with Analysts/Investors to discuss the operational & financial performance for the quarter ended on 30th June 2026, is scheduled as below: Day & Date: Wednesday, 5th August 2026 Time: 11:00 a.m. Registration Link and Access numbers: As per Annexure Copy of Earnings Call invite is annexed herewith and is also hosted on our website https://www.sudeeppharma.com/investor-relations/financial-results/#concall-invitation Kindly take the same on record. Thanking You. For Sudeep Pharma Limited Dimple Mehta Company Secretary & Compliance Officer M. No.: F13184 ENCL: A/a CIN: L24231GJ1989PLC013141 Registered Office: 129/1/A, G.I.D.C. Estate Nandesari, Baroda-391340, Gujarat, India. Phone No.: +91 265 2840656, 7624095107 Corporate Office: 601, 602, 6th Floor, Sears Towers-2, Gotri-Sevasi Road, Sevasi, Vadodara-390021, Gujarat, India Website: www.sudeepgroup.com, Email ID: mail@sudeepgroup.com CONFERENCE CALL SUDEEP PHARMA LIMITED Hosted by Nuvama Wealth Management India Equity Research July 27, 2026 Nuvama Wealth Management is hosting a conference call with the management of Sudeep Pharma Limited to discuss the Company’s Q1FY27 financial results on Wednesday, August 05, 2026 at 11.00 AM IST. Mr. Sujit Bhayani – Managing Director, Mr. Shanil Bhayani – Director, Mr. Ketan Vyas – Chief Financial Officer will represent on the call. Details of the conference call are as under: Time : 11.00 AM IST on Wednesday, August 05, 2026 Conference dial-in: India : Mumbai : Primary access number + 91 22 6280 1123 +91 22 7115 8024 USA : 1 866 746 2133 UK : 0 808 101 1573 Singapore Toll Free No. : 800 101 2045 Hong Kong Toll Free No. : 800 964 448 Call leader Mr. Archit Joshi For further information, please contact: Archit Joshi Nuvama Wealth Management Ltd. E-mail: Archit.Joshi@nuvama.com Express Join with DiamondPass™ Nuvama Research is also available on research.nuvama.com, Bloomberg – NUVA, Thomson Reuters and Factset Nuvama Wealth Management Ltd.